Clinical Oncology
Volume 19, Issue 5 , Pages 308-318 , June 2007

Identification of Differentially Expressed Genes Using Annealing Control Primer-based GeneFishing in Human Squamous Cell Cervical Carcinoma

  • Y.-W. Choi

      Affiliations

    • Department of Anesthesiology, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • Y.-W. Kim

      Affiliations

    • Catholic Research Institutes of Medical Science, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • S.-M. Bae

      Affiliations

    • Catholic Research Institutes of Medical Science, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • S.-Y. Kwak

      Affiliations

    • Catholic Research Institutes of Medical Science, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • H.-J. Chun

      Affiliations

    • Department of Biomedical Science, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • S.Y. Tong

      Affiliations

    • Department of Obstetrics and Gynecology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • H.N. Lee

      Affiliations

    • Department of Obstetrics and Gynecology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • J.C. Shin

      Affiliations

    • Department of Obstetrics and Gynecology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
    • ,
  • K.T. Kim

      Affiliations

    • Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Seoul, Republic of Korea
    • ,
  • Y.J. Kim

      Affiliations

    • Department of Obstetrics and Gynecology, College of Medicine, Hanyang University, Seoul, Republic of Korea
    • ,
  • W.-S. Ahn

      Affiliations

    • Department of Obstetrics and Gynecology, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea
    • Corresponding Author InformationAuthor for correspondence: Woong-Shick Ahn, MD, PhD, Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Republic of Korea. Tel.: +82-2-590-2786; Fax: +82-2-599-4120.

Received 7 September 2005 ,Revised 1 December 2006 ,Accepted 13 February 2007.

References 

  1. Chung HH, Jang MJ, Jung KW, et al. Cervical cancer incidence and survival in Korea: 1993–2002. Int J Gynecol Cancer. 2006;16:1833–1838
  2. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365–1371
  3. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus DNA in uterine cervical squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer. 1996;77:2275–2279
  4. Howley PM. Role of the human papillomaviruses in human cancer. Cancer Res. 1991;51:5019–5022
  5. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76–79
  6. Dyson N, Howley PM, Munger K. The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:943–947
  7. Padmanathan YA, Arivananthan MM. Dual detection of human herpesvirus-6 and human papillomavirus type 16 and 18 in cervical carcinoma. J Obstet Gynaecol. 1997;17:86–87
  8. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci. 1991;88:5523–5527
  9. Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol. 2003;102:765–773
  10. Gustafsson L, Adami HO. Natural history of cervical neoplasia; consistent results obtained by an identification technique. Br J Cancer. 1989;60:132–141
  11. Van Oortmarssen GJ, Habbema JD. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer. 1991;64:559–565
  12. Dellas A, Schultheiss E, Almendral AC, et al. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia. Int J Cancer. 1997;74:421–425
  13. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995;32:1309–1317
  14. Herrington CS. Human papillomaviruses (HPV) in gynecological cytology: from molecular biology to clinical testing. Cytopatholology. 1995;6:176–189
  15. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer. 1999;80:2008–2018
  16. Stollberg J, Urschiz J, Urban Z, Boyd CD. A quantitative evaluation of SAGE. Genome Res. 2000;10:1241–1248
  17. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270:467–470
  18. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257:967–971
  19. Hwang IT, Kim YJ, Kim SH, Kwak CI, Gu YY, Chun JY. Annealing control primer system for improving specificity of PCR amplification. Biotechniques. 2003;35:1180–1184
  20. Contag SA, Gostout BS, Clayton AC, Dixon MH, McGovern RM, Calhoun ES. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol. 2004;95:610–617
  21. Que N, Hamai Y, Mitani Y, et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 2004;64:2397–2405
  22. Shalon D. Gene expression micro-arrays: a new tool for genomic research. Pathol Biol. 1998;49:107–109
  23. Kihara C, Tsunoda T, Tanaka T, et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene expression profiles. Cancer Res. 2001;61:6474–6479
  24. Welss T, Papoutsaki M, Michel G, et al. Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential display PCR and expression array. Int J Cancer. 2003;104:66–72
  25. Seo MJ, Bae SM, Park KM, Ahn WS. Identification of gene expression and gene ontology classification by differential display RT-PCR in human cervical squamous cell carcinoma. Korean Soc Obstet Gynecol. 2004;47:684–693
  26. Kim BH, Bae SM, Seo MJ, Ahn WS. Changes of gene expression between HaCaT and SiHa cells using GeneFishing PCR. Korean J Gynecol Oncol Colposc. 2003;14:300–305
  27. Lee AY, Kim NH, Park SW. All trans-retinoic acid (ATRA) elevated eukaryotic translation initiation factor 4A1 (eIF4A1) mRNA in ATRA-responsive vitiliginous epidermis. Pigment Cell Res. 2004;17:659–667
  28. Komatsu K, Murata K, Kameyama M, et al. Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. Oncology. 2002;63:192–200
  29. Gebhardt C, Breitenbach U, Tuckermann JP, Dittrich BT, Richter KH, Angel P. Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene. 2002;21:4266–4276
  30. Ohan N, Sabourin D, Booth RA, Liu XJ. Xenopus laevis TRK-fused gene (TFG) is an SH3 domain binding protein highly expressed in the cement gland. Mol Reprod Dev. 2000;56:336–344
  31. Roccato E, Pagliardini S, Cleris L, et al. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation. Oncogene. 2003;22:807–818
  32. Battig P, Saudan P, Gunde T, Bachmann MF. Enhanced apoptotic activity of a structurally optimized form of galectin-1. Mol Immunol. 2004;41:9–18
  33. Ben-Yehuda S, Russell CS, Dix I, Beggs JD, Kupiec M. Extensive genetic interactions between PRP8 and PRP17/CDC40, two yeast genes involved in pre-mRNA splicing and cell cycle progression. Genetics. 2000;154:61–71
  34. Caccamo AE, Scaltriti M, Caporali A, et al. Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin. Biochem J. 2004;382:157–168
  35. Westendorf JM, Konstantinov KN, Wormsley S, et al. M phase phosphoprotein 10 is a human U3 small nucleolar ribonucleoprotein component. Mol Biol Cell. 1998;9:437–449
  36. Clark BR, Kelly SE, Fleming S. Calgranulin expression and association with the keratinocyte cytoskeleton. J Pathol. 1990;160:25–30
  37. Park JH, Park JS, Ju SK, et al. Clusterin mRNA expression in apoptotic and activated rat thymocytes. Cell Res. 2003;13:49–58
  38. Waters KM, Safe S, Gaido KW. Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. Toxicol Sci. 2001;63:47–56
  39. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem. 2003;278:11590–11600

PII: S0936-6555(07)00524-9

doi: 10.1016/j.clon.2007.02.010

Clinical Oncology
Volume 19, Issue 5 , Pages 308-318 , June 2007

Article Tools

* Image Usage & Resolution